You are here

  • Home
  • Archive
  • Volume 79, Issue 1
  • Sustained discontinuation of infliximab with a raising-dose strategy after obtaining remission in patients with rheumatoid arthritis: the RRRR study, a randomised controlled trial

Article metrics

Article menu
Rheumatoid arthritis
Sustained discontinuation of infliximab with a raising-dose strategy after obtaining remission in patients with rheumatoid arthritis: the RRRR study, a randomised controlled trial

 

Online download statistics by month:

Online download statistics by month: October 2019 to March 2024

AbstractFullPdf
Oct 201910111014327
Nov 2019540575188
Dec 2019475475136
Jan 2020443433139
Feb 202016115468
Mar 202014914761
Apr 202011210869
May 2020142139151
Jun 2020646245
Jul 2020868438
Aug 2020626037
Sep 20208584109
Oct 2020716942
Nov 2020656229
Dec 202061597
Jan 2021605924
Feb 2021454322
Mar 2021534821
Apr 2021404117
May 2021343320
Jun 2021565620
Jul 2021565528
Aug 2021393634
Sep 2021413925
Oct 2021656228
Nov 2021515024
Dec 202129278
Jan 2022635717
Feb 2022525317
Mar 2022817921
Apr 202210310327
May 2022727021
Jun 2022484814
Jul 2022535111
Aug 2022686519
Sep 2022585519
Oct 2022605614
Nov 2022454315
Dec 2022464615
Jan 2023363412
Feb 2023636210
Mar 2023383810
Apr 2023312812
May 2023191812
Jun 202328286
Jul 2023282712
Aug 202319174
Sep 202318179
Oct 202325259
Nov 202322227
Dec 202349499
Jan 202441356
Feb 2024453415
Mar 2024514958
Total535852832118